top of page

Pipeline

Homing Therapeutics focuses on developing transformative cell therapies through navigating therapeutic immune cells. By integrating advanced gene editing and chemical induction technologies, our products can significantly enhance the accessibility of CAR T cells in cancer maintenance sites.

Products

image.png

HoM-01

​Target Cells       

​

​

CAR T    ​​​​​

​Engineer Strategy       

 

Genetic      ​​​​​

​Receptor   

 

 

 

Receptor A        ​​​​​

Delivering Tissues

 

Bone Marrow

​Disease Indications       

 

 

ALL, NHL, MM    

image.png

HoM-02

​Target Cells       

 

​

CAR T    ​​​​​

​Engineer Strategy       

 

Chemical     ​​​​​

​Receptor   

 

 

 

Receptor B       ​​​​​

Delivering Tissues

 

Bone Marrow

​Disease Indications       

 

 

ALL, NHL, MM    

Road Map

Discovery &      IND-enabling              Phase I/IIA                   Phase III           Validation                                                                                                                     

image_edited_edited.png
image.png

HoM-01

HoM-02

image.png
2026                                                                              2029
2025                                                                              2028

    © 2025 by Homing Therapeutics Limited. All rights reserved.

    bottom of page